By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dainippon Sumitomo Pharma America Inc. 

One Bridge Plaza
Suite 510
Fort Lee  New Jersey  07024  U.S.A.
Phone: 201-592-2050 Fax: 201-592-6107



Company News
Dainippon Sumitomo Pharma America Inc. Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia 3/11/2010 11:54:41 AM
Dainippon Sumitomo Pharma America Inc. Announces the NDA Submission of Lurasidone to the FDA for the Treatment of Schizophrenia 1/5/2010 8:38:01 AM
Dainippon Sumitomo Pharma America Inc. Selects SAS(R) Solutions OnDemand: Drug Development to Manage Clinical Trial Data 11/2/2009 9:57:02 AM
Dainippon Pharmaceutical, Sumitomo Pharmaceuticals Co. Ltd. And Ono Pharmaceutical Company, Ltd. To Enter Into Joint Development And Marketing Agreement For Limaprost Alfadex, Oral PGE1 Derivative 12/7/2005 11:48:57 AM
Nipro Corporation To Purchase Dainippon Ink And Chemicals' Extracorporeal Membrane Oxygenation Business10/19/2005 5:13:12 PM
Dainippon Pharmaceutical , Eisai Company, Ltd. (ESALY.PK) Sign Licensing Agreement For Antiepileptic Agent Zonisamide10/19/2005 5:13:10 PM
Dainippon Pharmaceutical , Kowa Company Conclude Business Transfer Agreement10/19/2005 5:13:07 PM
Dainippon Pharmaceutical , ZOEGENE Corporation Conclude Joint Research Agreement In Diabetes And Obesity10/19/2005 5:13:07 PM
Dainippon Pharmaceutical And Kyorin Pharmaceutical Co., Ltd. To Collaborate In Development Of Drug Candidate For Diabetic Complication10/19/2005 5:13:06 PM
Kissei Pharmaceutical Co., Ltd., Dainippon Pharmaceutical Conclude Licensing Agreement For KGA-2727 Diabetes Drug Candidate10/19/2005 5:13:03 PM